2,5,7-substituted oxazolopyrimidine derivatives

US8785439B2 · kind B2 · utility

Assignee

• Sanofi · FR

Inventors

• Dieter Kadereit · Kelkheim, DE
• Matthias Schaefer · Frankfurt am Main, DE
• Stephanie Hachtel · Frankfurt am Main, DE
• Axel Dietrich · Frankfurt am Main, DE
• Thomas Huebschle · Frankfurt am Main, DE
• Andreas Gille · Frankfurt am Main, DE
• Katrin Hiss · Frankfurt am Main, DE

Key dates

• Filing date: Jan 12, 2011
• Grant date: Jul 22, 2014
• Expiry date: Jan 12, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to oxazolopyrimidine compounds of formula (I), where A, R1, R2 and R3 are defined as stated in the claims. The compounds of formula (I) are suitable, for example, for wound healing.